Trial Profile
An open-label, multiple-dose, two-treatment period study to evaluate the effect of oral BAF312 on the pharmacokinetics and pharmacodynamics of a monophasic oral contraceptive in healthy female volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Siponimod (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Multiple sclerosis; Pregnancy
- Focus Pharmacokinetics
- Sponsors Novartis
- 22 Sep 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 17 Apr 2012 New trial record